Synaptic Systems is a Biotech company with 10 employees which has put its focus on the development and production of antibodies against synaptic proteins. The program of available products is a mixture of polyclonal and monoclonal antibodies licensed from renowned scientists and antibodies developed by Synaptic Systems itself. Currently it represents one of the largest collections of antibodies against synaptic proteins worldwide.
Synaptic Systems has developed proprietary, specialized assays to monitor recycling vesicles in defined subpopulations of synapses and has the knowledge and experience to develop new antibodies and to test them for a set of different applications like immunoblotting, immunofluorescence, ELISA and Immunoprecipitation.
A close collaboration with academic partners and customers has always been a priority to combine our experience in the development of antibodies with the expertise of our partners in their field of research.
Main Tasks in this Project: The main task of this project partner is the generation and validation of monoclonal and polyclonal antibodies and antibody related research tools for the analysis of target proteins and/or corresponding protein complexes. Synaptic Systems has already available antibodies directed against various neuroligins, DLG, and active zone proteins that will be in the focus of investigation in the course of the project.